Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

United Therapeutics Buys Thymmune For Up To $300M

Дата публикации: 02-07-2026 16:50:06

Biotechnology firm United Therapeutics Corp. on Thursday revealed that it has agreed to buy a preclinical-stage biotech company focused on thymic cell therapies in a deal worth up to $300 million.

Основное содержимое страницы с новостью.

United Therapeutics Buys Thymmune For Up To $300M

By Jade Martinez-Pogue ( July 2, 2026, 4:50 PM EDT) -- Biotechnology firm United Therapeutics Corp. on Thursday revealed that it has agreed to buy a preclinical-stage biotech company focused on thymic cell therapies in a deal worth up to $300 million....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Tyson Foods покупает поставщика мяса для McDonald's0021-08-2018
2Lockheed in lead to buy naval tech group Ultra Maritime in $3.5bn deal0502-07-2026
3Linklaters-Led Genel Energy To Buy Capricorn For $360M0702-07-2026
4Dragons' Den star Tej Lalvani makes £1BILLION as he sells family business Vitabiotics promoted by Tess Daly and David Gandy08.2625-07-2026
52 Firms Lead Merck's $11.3B Bio-Techne Life Sciences Deal0725-06-2026
6Wasserman Near Deal to Sell Agency to Providence for $3.4B010.3324-07-2026
7AI Drug Discovery Biz Valued At $3.8B After Series C Round0514-07-2026
8Skadden, Baker McKenzie Guide $7B Onsemi, Synaptics Deal0526-06-2026
9Qualcomm Buys Buzzy Chip Startup Modular for Nearly $4 Billion5724-06-2026
10GSK completes acquisition of Nuvalent, Inc. 011.915-07-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 5. Источник: www.law360.com.